We are live on
!
Find out more
JIR
James Investment Research Portfolio holdings
AUM
$984M
1-Year Est. Return
36.03%
This Fund
S&P 500
This Quarter
Est. Return
+9.37%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$715M
AUM Growth
+$14.1M
(+2%)
Cap. Flow
-$42.6M
Cap. Flow
% of AUM
-5.96%
Top 10 Holdings %
Top 10 Hldgs %
23.38%
Holding
618
New
89
Increased
96
Reduced
219
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$5.99M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.59M |
| 3 |
Invesco S&P SmallCap 600 Revenue ETF
RWJ
|
+$2.47M |
| 4 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
+$2.13M |
| 5 |
Invesco Variable Rate Investment Grade ETF
VRIG
|
+$1.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$6.13M |
| 2 |
Apple
AAPL
|
+$5.41M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$3.62M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$2.69M |
| 5 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.13% |
| 2 | Healthcare | 11.5% |
| 3 | Financials | 10.78% |
| 4 | Consumer Discretionary | 6.97% |
| 5 | Industrials | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MZTI
401
The Marzetti Company
MZTI
$3.1B
| $29K | ﹤0.01% |
+148
| New | +$28.1K |
|
402
Dr. Reddy's Laboratories
RDY
$10.2B
| $29K | ﹤0.01% |
+2,805
| New | +$30.3K |
|
403
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$193M
| $29K | ﹤0.01% |
900
-6,000
| -87% | -$190K |
|
|
VMW
404
DELISTED
VMware, Inc
VMW
| $29K | ﹤0.01% |
+234
| New | +$27K |
|
405
Biogen
BIIB
$32.7B
| $28K | ﹤0.01% |
+102
| New | +$28.8K |
|
406
Franco-Nevada
FNV
$51.6B
| $28K | ﹤0.01% |
+207
| New | +$27.3K |
|
407
Constellation Brands
STZ
$23B
| $28K | ﹤0.01% |
121
-187
| -61% | -$44.8K |
|
408
TSMC
TSM
$2.17T
| $28K | ﹤0.01% |
381
-147
| -28% | -$10.6K |
|
409
Addus HomeCare
ADUS
$2.25B
| $27K | ﹤0.01% |
+274
| New | +$28.7K |
|
410
Box
BOX
$4.63B
| $27K | ﹤0.01% |
+858
| New | +$24.5K |
|
411
Doximity
DOCS
$4.41B
| $27K | ﹤0.01% |
+783
| New | +$23.9K |
|
412
DexCom
DXCM
$33.6B
| $27K | ﹤0.01% |
+239
| New | +$26.2K |
|
413
Ryman Hospitality Properties
RHP
$8.99B
| $27K | ﹤0.01% |
+334
| New | +$28.6K |
|
|
CVLY
414
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $27K | ﹤0.01% |
1,127
| – | – |
|
415
General Mills
GIS
$21.4B
| $26K | ﹤0.01% |
+310
| New | +$25.2K |
|
416
Global Payments
GPN
$24.6B
| $26K | ﹤0.01% |
+262
| New | +$27.3K |
|
417
MP Materials
MP
$10.6B
| $26K | ﹤0.01% |
+1,083
| New | +$32.8K |
|
418
PENN Entertainment
PENN
$2.39B
| $26K | ﹤0.01% |
+884
| New | +$28.7K |
|
419
ResMed
RMD
$34B
| $26K | ﹤0.01% |
125
-901
| -88% | -$198K |
|
420
Shopify
SHOP
$193B
| $26K | ﹤0.01% |
+753
| New | +$25.7K |
|
421
Twilio
TWLO
$35.1B
| $26K | ﹤0.01% |
+531
| New | +$30.2K |
|
422
Bristol-Myers Squibb
BMY
$138B
| $25K | ﹤0.01% |
350
| – | – |
|
423
Harte-Hanks
HHS
$31.8M
| $25K | ﹤0.01% |
+2,100
| New | +$23.2K |
|
424
iShares Biotechnology ETF
IBB
$10.8B
| $25K | ﹤0.01% |
190
| – | – |
|
425
JPMorgan Ultra-Short Income ETF
JPST
$40.8B
| $25K | ﹤0.01% |
+500
| New | +$25.1K |
|
Similar funds
MHIC
CVM
CPBTD
SLG
LI
IAM
APFP
SAA
James Investment Research's Q4 2022 Portfolio in Review
As of Q4 2022, James Investment Research held 618 positions worth $715M, up 2% from $701M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
James Investment Research withdrew a net $42.6M in Q4 2022, closing 33 positions and reducing 219 holdings. Its most notable exit was Vanguard FTSE All-World ex-US ETF, an estimated $1.26M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, James Investment Research opened a new position in iShares Core S&P Small-Cap ETF worth $420K.
- James Investment Research's largest Q4 2022 buy was iShares Core S&P Small-Cap ETF: 4,441 shares worth $420K.
- James Investment Research added most to iShares 20+ Year Treasury Bond ETF in Q4 2022, an estimated $5.99M increase.
- James Investment Research's biggest Q4 2022 reduction was Lam Research, cutting an estimated $6.13M.
- James Investment Research fully exited Vanguard FTSE All-World ex-US ETF in Q4 2022, selling an estimated $1.26M.
- James Investment Research's ten largest holdings make up 23% of its $715M portfolio in Q4 2022.
- James Investment Research opened 89 new positions and closed 33 in Q4 2022.
- James Investment Research's portfolio value rose 2% quarter-over-quarter to $715M.
Based on James Investment Research's 13F filing for Q4 2022, filed 30 Jan 2023.